Candriam SCA’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-172,584
| Closed | -$2.49M | – | 892 |
|
|
2022
Q3 | $2.49M | Hold |
172,584
| – | – | 0.02% | 537 |
|
|
2022
Q2 | $2.61M | Hold |
172,584
| – | – | 0.02% | 445 |
|
|
2022
Q1 | $2.05M | Sell |
172,584
-11,108
| -6% | -$132K | 0.01% | 533 |
|
|
2021
Q4 | $2.98M | Buy |
183,692
+5,511
| +3% | +$89.3K | 0.02% | 469 |
|
|
2021
Q3 | $5.09M | Hold |
178,181
| – | – | 0.03% | 396 |
|
|
2021
Q2 | $9.26M | Sell |
178,181
-1,764
| -1% | -$91.7K | 0.06% | 298 |
|
|
2021
Q1 | $8.56M | Sell |
179,945
-1
| -0% | -$48 | 0.07% | 275 |
|
|
2020
Q4 | $8.91M | Sell |
179,946
-2,758
| -2% | -$137K | 0.07% | 282 |
|
|
2020
Q3 | $7.01M | Buy |
182,704
+17,707
| +11% | +$680K | 0.07% | 293 |
|
|
2020
Q2 | $7.13M | Buy |
164,997
+107,451
| +187% | +$4.64M | 0.08% | 272 |
|
|
2020
Q1 | $1.76M | Buy |
57,546
+20
| +0% | +$611 | 0.02% | 552 |
|
|
2019
Q4 | $1.8M | Buy |
+57,526
| New | +$1.8M | 0.02% | 569 |
|